Fact-checked by Grok 2 weeks ago

Myoglobin

Myoglobin is a monomeric heme-containing protein predominantly expressed in skeletal and cardiac muscle cells, where it reversibly binds oxygen to store it intracellularly and facilitate its diffusion to mitochondria during periods of high metabolic demand.^[1]^[2] Encoded by the MB gene located on human chromosome 22q12-13, myoglobin consists of a single polypeptide chain of 153 amino acids folded into eight alpha-helices that enclose a heme prosthetic group, enabling selective oxygen binding at the iron atom within the porphyrin ring.^[3]^[4] The three-dimensional structure of myoglobin, determined by John Kendrew in 1959 using X-ray crystallography on sperm whale myoglobin, was the first atomic-resolution model of a protein, revealing the principles of globular protein folding and ligand binding that underpin much of modern structural biology.^[5]^[6] This breakthrough earned Kendrew the 1962 Nobel Prize in Chemistry, shared with Max Perutz for their work on globular proteins.^[6] Beyond oxygen storage, myoglobin modulates intracellular oxygen gradients, scavenges nitric oxide to prevent interference with respiration, and may catalyze reactions involving reactive oxygen species, highlighting its multifaceted role in muscle physiology.^[7]^[1] Its oxygen dissociation curve, with a higher affinity than hemoglobin, ensures efficient release under hypoxic conditions within contracting muscle fibers.^[8]

History and Discovery

Early Identification and Isolation

The muscle pigment responsible for the red color of skeletal and cardiac tissues was first spectroscopically detected by Charles A. MacMunn in 1886, who distinguished it from hemoglobin in blood and named it myohaematin based on its absorption bands in muscle extracts.^[9] MacMunn's observations, made using a spectroscope on tissue samples from various animals, revealed characteristic bands at wavelengths corresponding to reduced and oxidized forms, but his work was initially dismissed by contemporaries like Hoppe-Seyler as artifacts or hemoglobin derivatives.^[10] In 1897, K. A. H. Mörner conducted more precise spectroscopic analyses on extracted muscle pigments from mammals, confirming a distinct heme-containing protein separate from hemoglobin, which he termed myohaemoglobin (later myochrome) due to its unique spectral properties, including sharper absorption bands in the Soret region.^[11] Mörner's extraction involved acidifying minced muscle tissue to release the pigment, followed by salting out with ammonium sulfate, enabling differentiation via reduced oxygen affinity compared to blood hemoglobin.^[7] Advances in purification occurred in the early 1930s, with Hugo Theorell developing methods to isolate myoglobin from horse heart muscle by sequential precipitation with ammonium sulfate at specific saturations (around 60-80%), acidification to pH 6-7, and crystallization from concentrated solutions at low temperatures.^[12] This yielded pure, crystalline myoglobin with a molecular weight determined via osmotic pressure and early ultracentrifugation studies at approximately 17,000-17,500 Da, establishing its monomeric structure in contrast to hemoglobin's tetrameric assembly of ~68,000 Da.^[12] Theorell's preparations demonstrated reversible oxygenation without the cooperative binding seen in hemoglobin, confirming myoglobin's role as a distinct oxygen-binding protein through solubility and sedimentation analyses.^[13]

Structural Elucidation by X-ray Crystallography

John C. Kendrew and his team at the Medical Research Council Laboratory of Molecular Biology initiated X-ray crystallographic studies on sperm whale (Physeter catodon) myoglobin in the late 1940s, selecting this protein due to its ability to form well-diffracting crystals suitable for structural analysis.^[5] By the mid-1950s, they had collected extensive diffraction data from type A monoclinic crystals grown in ammonium sulfate solutions.^[14] The primary challenge was solving the phase problem, addressed through the multiple isomorphous replacement method using heavy-atom derivatives, such as p-chloromercuribenzoate for mercury labeling and potassium platinum chloride for platinum substitution at specific cysteine and histidine residues.^[15] These derivatives provided phase information by altering scattering amplitudes without significantly disrupting crystal isomorphism.^[5] In 1958, computational analysis of the three-dimensional diffraction data, aided by early electronic computers like the EDSAC, produced a low-resolution electron density map at 6 Å, disclosing the protein's overall fold as a compact bundle of eight alpha-helices enclosing a central cavity.^[5] This map marked the first visualization of a protein's tertiary structure, revealing rod-like densities consistent with alpha-helices and validating Linus Pauling's 1951 theoretical model of the right-handed alpha-helix as a prevalent secondary structure in proteins.^[16] The helical content exceeded initial expectations, comprising about 75% of the polypeptide chain, and demonstrated the feasibility of helical folding in globular proteins despite earlier skepticism regarding its stability in aqueous environments.^[17] Subsequent refinement, incorporating higher-resolution data collected via improved instrumentation, yielded a 2 Å atomic model in 1960, enabling precise tracing of the 153-residue chain, placement of side chains, and localization of the heme group within the helical pocket.^[18] This high-resolution structure elucidated key structural features, such as the proximal histidine coordination to the heme iron and the distal pocket geometry, foundational for understanding oxygen binding.^[5] Kendrew's achievements, representing the inaugural atomic-resolution determination of a protein structure, earned him the 1962 Nobel Prize in Chemistry, shared with Max Perutz for complementary work on hemoglobin.^[6]

Molecular Structure and Properties

Primary Sequence and Folding

Myoglobin's primary structure in humans comprises a single polypeptide chain of 154 amino acids.^[19] Approximately half of these residues possess nonpolar side chains, which cluster internally to drive folding via hydrophobic interactions, while polar and charged residues predominate on the exterior for aqueous solubility.^[20] The sequence exhibits high conservation across vertebrate species, reflecting functional constraints on the oxygen-binding pocket and overall fold; for instance, myoglobins from elephant and sperm whale share 81% amino acid identity.^[21] The protein folds into a compact globular tertiary structure dominated by alpha-helical secondary elements, comprising eight helices designated A through H and spanning about 75% of the chain length.^[22] These helices are linked by short loops, with the arrangement forming a characteristic "globin fold" stabilized primarily by a central hydrophobic core of nonpolar residues that minimizes solvent exposure and entropy loss upon folding.^[23] Surface-exposed polar residues facilitate solubility in the cytoplasmic milieu of muscle cells, while intra-helical hydrogen bonds and packing of the core provide rigidity against unfolding.^[22] This architecture emerges from the primary sequence through cooperative hydrophobic collapse, as evidenced by folding studies showing rapid formation of helical intermediates prior to core packing.^[24] The conserved helical bundle creates two interconnected hydrophobic networks, one encompassing helices A, B, E, and H, and another involving C, D, F, and G, which collectively resist thermal denaturation and maintain structural integrity under physiological conditions.^[25] Sequence variations across species primarily occur in loop regions or surface positions, preserving the core's apolar character essential for stability.^[26]

Heme Prosthetic Group and Binding Mechanism

The heme prosthetic group of myoglobin is a ferroprotoporphyrin IX complex featuring a ferrous iron (Fe²⁺) ion at its center, embedded within a hydrophobic pocket formed by the globin fold.^[1] This non-covalently bound cofactor enables reversible oxygen binding, with the iron coordinated axially by the imidazole nitrogen of the proximal histidine residue (His93 in sperm whale myoglobin).^[1] The heme's porphyrin ring provides a planar scaffold that positions the iron for ligand interaction while shielding it from solvent.^[1] In the deoxy form, the Fe²⁺ adopts a high-spin (S=2) electronic configuration, remaining pentacoordinate and displaced approximately 0.4–0.6 Å out of the heme plane toward the proximal histidine.^[27] Oxygen binding at the sixth coordination site induces a transition to a low-spin (S=0) state, pulling the iron into the porphyrin plane and triggering a conformational shift in the F helix attached to His93.^[27] This structural rearrangement facilitates tight packing around the ligand, enhancing stability.^[1] The distal histidine (His64) plays a critical role in the binding mechanism by donating a hydrogen bond to the bound O₂ molecule, stabilizing the bent Fe–O–O geometry (bond angle ~120°) characteristic of oxy-myoglobin.^[28] This interaction discriminates against carbon monoxide (CO), which prefers linear binding, by imposing steric hindrance that reduces CO affinity by a factor of ~20–200 compared to free heme.^[29] Additionally, the hydrogen bond from His64 impedes auto-oxidation, the spontaneous conversion to ferric metmyoglobin (Fe³⁺), which occurs via dissociation of superoxide (O₂⁻) and renders the protein inactive for oxygen transport.^[30] Mutational studies confirm that replacing His64 increases auto-oxidation rates by 10–100 fold, underscoring its protective function.^[30] The hydrophobic environment of the pocket further minimizes solvent access, reducing protonation events that could promote oxidation.^[28]

Evolutionary Conservation

Myoglobin belongs to the globin superfamily, an ancient protein family that originated approximately 4 billion years ago as a basic structural fold for proto-oxygen binding under anaerobic primordial conditions.^[31] This superfamily predates the gene duplication events in early vertebrates that produced the α- and β-globin subunits of tetrameric hemoglobin around 500 million years ago, positioning myoglobin as a more ancestral, monomeric form within the lineage.^[32] Sequence analyses across diverse taxa, including vertebrates and invertebrates like annelids, reveal striking conservation of the core globin domain, with invariant residues at key positions such as the proximal (F8) and distal (E7) histidines essential for heme iron coordination.^[33] This homology, often exceeding 30-40% identity between mammalian species despite divergence over hundreds of millions of years, indicates profound selective constraints to maintain the three-over-three α-helical sandwich fold and oxygen-binding pocket against mutational drift.^[34] In extremophile and specialized lineages, such as Antarctic notothenioid fishes, myoglobin coding sequences show minimal variation among expressing species, with synonymous substitutions dominating non-coding regions, further evidencing purifying selection on functional exons.^[35] Similarly, fossorial mammals like moles exhibit conserved myoglobin primary structures adapted for hypoxia tolerance, prioritizing stability in low-oxygen burrows without compromising the canonical binding sites.^[36] Diving mammals, including cetaceans and pinnipeds, demonstrate convergent sequence adaptations under apnea-related selective pressures, evolving elevated net positive surface charges via lineage-specific amino acid substitutions to boost protein solubility and permit myoglobin concentrations up to tenfold higher than in terrestrial counterparts.^[37] These changes, reconstructed through ancestral protein resurrection, preserve over 80% structural overlap with basal globins while enhancing resistance to macromolecular crowding in densely packed muscle fibers during prolonged submersion.^[26] Such modifications highlight how niche-specific pressures can drive localized sequence divergence atop a highly conserved scaffold, enabling elevated oxygen storage without altering the core heme-binding apparatus.^[38]

Physiological Function

Oxygen Storage and Delivery in Muscle

Myoglobin serves as the primary oxygen storage protein in vertebrate skeletal and cardiac muscle, binding molecular oxygen reversibly to its heme prosthetic group via the equilibrium Mb + O₂ ⇌ MbO₂.^[39]^[40] This monomeric protein exhibits a hyperbolic oxygen dissociation curve, characterized by non-cooperative binding and a high affinity with a P₅₀ value of approximately 2-3 mmHg, enabling near-complete saturation at typical intracellular partial pressures of oxygen (20-40 mmHg).^[1]^[41] In contrast, hemoglobin's sigmoidal curve reflects cooperative binding among its tetrameric subunits, with a higher P₅₀ of about 26 mmHg suited for oxygen transport in blood.^[1] The hyperbolic binding kinetics follow Michaelis-Menten-like behavior, allowing myoglobin to act as an efficient oxygen reservoir that remains largely oxygenated under normoxic conditions but releases O₂ when tissue PO₂ drops during intense contraction or transient ischemia.^[1] This delivery mechanism supports sustained aerobic metabolism by providing oxygen directly to mitochondrial cytochrome c oxidase when hemoglobin dissociation alone is insufficient, particularly in fast-twitch fibers with limited vascular supply.^[8] In hypoxia-adapted species, such as diving mammals, myoglobin concentrations in muscle can reach 5-10% of cytosolic protein by mass, far exceeding levels in terrestrial counterparts, thereby amplifying storage capacity to sustain prolonged apnea.^[42] For instance, in the bottlenose whale, elevated myoglobin facilitates dives exceeding 2 hours by maintaining intracellular O₂ availability for ATP production via oxidative phosphorylation despite circulatory adjustments that prioritize vital organs.^[43] This adaptation underscores myoglobin's role in buffering oxygen deficits, with evolutionary increases in expression correlating to dive duration across pinnipeds and cetaceans.^[42]

Facilitation of Oxygen Diffusion

Myoglobin enhances intracellular oxygen transport in muscle fibers by serving as a diffusible carrier that binds O₂ near the cell membrane and releases it toward consuming sites like mitochondria, effectively increasing the oxygen flux beyond what free diffusion alone would permit under Fick's first law, where flux J = -D \frac{\partial C}{\partial x} and the presence of mobile myoglobin-bound O₂ raises the effective diffusion coefficient D.^[44] This facilitation arises because myoglobin's rapid on-off kinetics for O₂ binding—characterized by an association rate constant of approximately $1.3 \times 10^7 \, \mathrm{M^{-1} s^{-1}} and dissociation rate of $10-20 \, \mathrm{s^{-1}} at physiological conditions—allow it to traverse the cytosol while maintaining a steeper average concentration gradient compared to unbound O₂ alone.^[45] Experimental measurements in isolated muscle preparations confirm that myoglobin's contribution elevates the apparent O₂ diffusivity by 1.5- to 3-fold, depending on saturation levels and fiber type.^[46] The abundance of myoglobin within a typical mammalian skeletal muscle fiber—reaching concentrations of 0.2-1 mM, equivalent to roughly 10^4-10^5 molecules per μm² of cross-sectional area—multiplies this facilitative effect, as the aggregate carrier capacity linearly scales with total myoglobin content per Fickian principles, enabling sustained O₂ supply to distal mitochondria during elevated demand without relying solely on extracellular gradients. Mathematical models incorporating myoglobin's diffusion coefficient (around $1.2 \times 10^{-7} \, \mathrm{cm^2 s^{-1}}) and binding stoichiometry predict that this density prevents intracellular PO₂ drops below critical thresholds in high-oxidative fibers, with facilitation becoming most pronounced at partial desaturations (20-50% MbO₂).^[47] In ischemia-reperfusion scenarios, such as those modeled in perfused heart or skeletal muscle preparations, myoglobin-mediated shuttling accelerates O₂ redistribution upon reoxygenation, reducing the time lag for mitochondrial resupply and mitigating transient hypoxia; for instance, fluorescence-based imaging in cardiomyocytes reveals spatially resolved MbO₂ gradients that resolve faster in wild-type versus myoglobin-deficient models, underscoring its role in flux augmentation during recovery from oxygen deprivation.^[45] These observations align with biophysical assays showing myoglobin's facilitation prevents localized anoxia in fiber cores post-ischemia, though its efficacy diminishes if autoxidation to metmyoglobin exceeds 10-20% under prolonged stress.^[44]

Metabolic Roles Beyond Oxygen Transport

Myoglobin demonstrates nitrite reductase activity in its deoxygenated state, particularly under hypoxic conditions where oxygen tension is low, reducing nitrite (NO₂⁻) to nitric oxide (NO).^[48] This enzymatic function was characterized through spectroscopic assays, including stopped-flow spectrophotometry, revealing that deoxymyoglobin reduces nitrite at a rate approximately 36 times faster than deoxyhemoglobin due to its lower heme reduction potential and monomeric structure, which facilitates substrate access.^[48] Empirical measurements via chemiluminescence detection confirmed NO production rates increasing with decreasing pH and oxygen levels, mimicking physiological ischemia.^[49] The generated NO contributes to hypoxic vasodilation by activating soluble guanylate cyclase in vascular smooth muscle, thereby elevating cyclic GMP and promoting vessel relaxation to enhance blood flow and oxygen delivery to tissues.^[50] In cardiac tissue, myoglobin-dependent nitrite reduction to NO was shown in isolated perfused hearts under hypoxia, where myoglobin knockout abolished nitrite-mediated vasodilation, as quantified by pressure-flow relationships and NO-sensitive electrodes.^[50] Additionally, this NO inhibits cytochrome c oxidase in mitochondria, reducing oxygen consumption and preserving cellular viability during ischemia-reperfusion, as evidenced by respirometry assays in myoglobin-expressing cardiomyocytes versus knockouts.^[51] These roles position myoglobin as a metabolic regulator that integrates oxygen sensing with nitric oxide signaling under low-oxygen stress.^[52]

Comparative Biochemistry

Key Differences from Hemoglobin

Myoglobin and hemoglobin differ fundamentally in their oligomeric state, with myoglobin functioning as a monomeric protein comprising a single polypeptide chain and one heme prosthetic group, while hemoglobin is a heterotetramer consisting of two α and two β subunits, each bearing a heme group. This structural disparity precludes cooperative interactions in myoglobin, resulting in independent oxygen binding at its sole heme, whereas hemoglobin's subunit interfaces enable allosteric conformational shifts between tense (T) and relaxed (R) states, promoting sequential oxygen binding that enhances overall affinity after initial ligation.^[1] The oxygen dissociation curve of myoglobin is hyperbolic, indicative of non-cooperative binding and a high intrinsic affinity (P₅₀ ≈ 2–3 mmHg), allowing efficient oxygen sequestration at low partial pressures typical of muscle interiors. Hemoglobin, by contrast, displays a sigmoidal curve due to positive cooperativity (Hill coefficient ≈ 2.8), with a lower affinity (P₅₀ ≈ 26 mmHg) that facilitates oxygen loading in lungs and unloading in tissues.^[40]^[1] Myoglobin's oxygen affinity remains unaffected by allosteric modulators such as 2,3-bisphosphoglycerate (2,3-BPG), which binds exclusively to the deoxyhemoglobin tetramer's central cavity—formed by the β subunits—stabilizing the low-affinity T-state and shifting hemoglobin's curve rightward by up to 50% under physiological concentrations (≈5 mM in erythrocytes). Absent this binding pocket and subunit assembly, myoglobin exhibits invariant affinity across physiological pH and effector gradients, underscoring its role in stable storage rather than regulated transport.^[53]^[54]

Similarities and Shared Evolutionary Origins

Myoglobin and hemoglobin belong to the ancient globin superfamily, which includes oxygen-binding proteins distributed across bacteria, archaea, protists, plants, and animals, indicating a shared evolutionary origin predating the vertebrate-invertebrate divergence more than 800 million years ago.^[55] The common ancestor of these proteins was likely a monomeric globin similar in structure to modern myoglobin, with hemoglobin arising through subsequent gene duplication and assembly into tetrameric forms.^[56] This ancestral globin primarily functioned in oxygen scavenging or protection against reactive species, with specialized transport and storage roles evolving later in vertebrates.^[31] Both proteins share the canonical globin fold, characterized by eight alpha-helices (labeled A–H) enclosing a heme-binding pocket, a tertiary structure conserved across the superfamily to accommodate the porphyrin ring and enable reversible ligand binding.^[31] Key residues in the heme pocket, including the proximal histidine at position F8 that coordinates the iron atom axially, and the distal histidine at E7 that hydrogen-bonds to bound dioxygen, are invariant in vertebrate myoglobins and hemoglobin subunits, ensuring similar binding geometries despite functional divergence.^[57] Amino acid sequence identity between myoglobin and individual hemoglobin alpha or beta chains averages around 25%, underscoring their descent from a single primordial gene while allowing adaptations like cooperativity in hemoglobin.^[58] Phylogenetic analyses of globin genes reveal that myoglobin (encoded by the MB locus on human chromosome 22) and hemoglobin clusters (on chromosomes 11 and 16) arose from tandem duplications of an proto-globin gene in early vertebrates, with the monomeric storage function of myoglobin representing the more primitive state retained for intracellular oxygen buffering in muscle tissues.^[55] This shared heritage is evident in non-vertebrate homologs, such as annelid erythrocruorins and bacterial hemoglobins, which exhibit analogous heme coordination and fold stability, supporting a deep evolutionary conservation driven by selective pressure for oxygen homeostasis.^[31]

Role in Pathology and Diagnostics

Association with Rhabdomyolysis and Myoglobinuria

Rhabdomyolysis, characterized by the rapid dissolution of skeletal muscle fibers, results in the massive release of intracellular contents, including myoglobin, into the bloodstream, often manifesting as myoglobinuria with dark, cola-colored urine.^[59] Common precipitants include severe physical trauma, such as crush injuries; extreme muscular exertion, as in marathon running or military training; and pharmacological agents like statins, which impair muscle cell integrity and amplify damage under stress.^[60]^[61] The risk escalates with concurrent factors, such as statin use combined with intense exercise, where myoglobin efflux overwhelms renal clearance capacity.^[62] This myoglobin overload directly contributes to acute kidney injury (AKI) through nephrotoxic effects, with plasma myoglobin levels exceeding 15,000 μg/L strongly correlating with AKI onset and dialysis requirement.^[63] Histological examinations of affected kidneys reveal granular casts composed of myoglobin in distal tubules, causing mechanical obstruction, back-pressure atrophy, and impaired glomerular filtration.^[64] Empirical biopsy data confirm that these Tamm-Horsfall protein-myoglobin aggregates precipitate in acidic, concentrated urine, exacerbating ischemic tubular damage independent of hemoglobinuria.^[65] While oxidative stress and vasoconstriction play roles, tubular obstruction remains the primary causal pathway evidenced by autopsy and biopsy findings in rhabdomyolysis cases.^[66]

Clinical Biomarkers and Testing

Serum myoglobin levels are measured as an early indicator of skeletal muscle injury, particularly in rhabdomyolysis, where release from damaged myocytes precedes elevations in creatine kinase (CK).^[67] Immunoassays, including enzyme-linked immunosorbent assays (ELISA) and chemiluminescent microparticle assays, enable rapid quantification in serum or plasma, often within minutes to hours for point-of-care testing.^[68] ^[69] These methods detect myoglobin concentrations typically exceeding 100-200 ng/mL as suggestive of significant muscle breakdown, though thresholds vary by assay.^[67] Compared to CK-MM, the predominant muscle isoform of creatine kinase, myoglobin demonstrates superior early sensitivity, with detectable rises within 1-3 hours post-injury versus 3-12 hours for CK.^[70] However, myoglobin's plasma half-life of 2-3 hours leads to swift normalization, even as muscle damage persists, rendering serial measurements unreliable for monitoring disease progression or resolution.^[59] CK-MM, with a half-life exceeding 36 hours, thus serves as the primary biomarker for confirming rhabdomyolysis and assessing severity, often requiring levels >5 times the upper reference limit (e.g., >1,000 U/L).^[71] Urine myoglobin testing complements serum assays by identifying myoglobinuria, confirmed via immunoassay when dipstick positive for blood but negative for red cells.^[70] Limitations of myoglobin testing include its low specificity, as elevations can occur from non-rhabdomyolytic causes like strenuous exercise or hemolysis, and its brief detectability window, which may yield false negatives if sampling is delayed beyond 6-8 hours.^[67] Alone, myoglobin lacks robust prognostic utility for outcomes such as acute kidney injury, as peak levels do not independently predict complications like dialysis need or mortality; instead, it informs initial triage but requires integration with CK trends, renal function, and clinical context.^[72] Guidelines emphasize CK over myoglobin for routine diagnostics due to these constraints.^[70]

Contributions to Oxidative Stress

Myoglobin contributes to oxidative stress through its heme iron, which under pathological conditions such as ischemia-reperfusion injury undergoes oxidation to the ferryl species (MbFe^{IV}=O), a highly reactive form capable of generating reactive oxygen species (ROS) including superoxide and hydroxyl radicals via Fenton-like reactions.^[73] This process is initiated by hydrogen peroxide or peroxynitrite, leading to heme degradation, free iron release, and subsequent lipid peroxidation, protein oxidation, and DNA damage in muscle and adjacent tissues.^[74] In myocardial ischemia-reperfusion models, myoglobin exhibits two-phase oxidation: initial formation of metmyoglobin followed by ferrylmyoglobin accumulation, which correlates with elevated ROS levels and enlarged infarct sizes as observed in isolated rat hearts and imaging studies.^[74] Ferryl myoglobin exacerbates oxidative damage during reperfusion by catalyzing redox cycling that propagates ROS bursts, contributing to cellular injury in conditions like rhabdomyolysis and acute kidney injury where myoglobinuria releases the protein systemically.^[73] Causal evidence from 2020s animal models demonstrates that myoglobin-derived iron induces ferroptosis through iron overload and lipid peroxidation in kidney tubular cells, independent of hemoglobin effects, with iron chelators like deferasirox reducing tissue damage by limiting ROS propagation.^[73]^[75] Endogenous antioxidants, such as ergothioneine and nitrite-derived species, mitigate ferryl myoglobin's reactivity by reducing it back to ferric metmyoglobin, thereby attenuating ROS-mediated inflammation and necrosis in ischemic tissues.^[73] Recent in vitro and ex vivo studies confirm that while myoglobin's peroxidatic activity drives oxidative stress in inflammation-associated heme release, targeted interventions like herbal antioxidants (e.g., glycyrrhizin) suppress these pathways in diabetic and reperfusion models.^[73]

Applications in Food Science

Influence on Meat Color and Quality

Myoglobin, the primary pigment in skeletal muscle, determines the color of fresh meat through its oxygenation states: deoxymyoglobin imparts a purplish-red hue under anaerobic conditions, oxymyoglobin produces the desirable cherry-red "bloom" upon exposure to oxygen, and metmyoglobin results in an unappealing brown discoloration via oxidation.^[76] Higher myoglobin concentrations correlate with darker red meat colors, varying by species and muscle type, with beef exhibiting elevated levels compared to pork or poultry.^[77] Meat quality perception is heavily influenced by this color stability, as rapid metmyoglobin formation signals spoilage to consumers despite the meat remaining microbiologically safe.^[78] In aerobic packaging, oxygen facilitates myoglobin blooming within minutes, forming a stable oxymyoglobin layer on the surface that enhances visual appeal, whereas vacuum packaging maintains deoxymyoglobin, yielding a darker, less vibrant appearance until air exposure triggers delayed blooming.^[79] Vacuum conditions limit oxygen availability, reducing metmyoglobin accumulation and preserving color longer during storage by minimizing oxidation, though reoxygenation post-opening can still produce bloom if myoglobin remains functional.^[80] This packaging differential affects quality by extending shelf life in vacuum (up to 23-36 days depending on conditions) versus aerobic systems, where surface discoloration accelerates due to unchecked myoglobin autoxidation.^[81] Myoglobin stability, assessed via spectrophotometry measuring absorbance at wavelengths like 525 nm for oxymyoglobin and 630 nm for metmyoglobin, declines at lower pH values typical of postmortem muscle (e.g., 5.3-5.6 in pale, soft, exudative meat), promoting protein denaturation and hastening brown pigment formation.^[82] At pH below 5.6, metmyoglobin solubility decreases and thermal denaturation increases, compromising color retention even under controlled packaging, while higher pH (above 6.0) enhances redox stability and delays oxidation.^[83] These pH-driven changes indirectly influence perceived texture through associated protein alterations, such as increased drip loss from denatured sarcoplasmic proteins, though myoglobin's primary impact remains visual.^[84]

Processing Effects and Culinary Implications

Heat denaturation of myoglobin in meat occurs progressively, beginning at approximately 55°C for certain forms like metmyoglobin under acidic conditions (pH 5), with complete denaturation typically achieved by 80°C, resulting in the release of the heme prosthetic group and a shift in meat color from red or pink to brown due to oxidation and structural unfolding of the protein.^[85]^[83] This color transition is influenced by factors such as the initial redox state of myoglobin (e.g., oxymyoglobin denatures to brown more readily than deoxymyoglobin, which may retain redness up to 65°C), pH (higher pH delays denaturation and preserves red hues), and cooking endpoint temperature, with lower temperatures (e.g., 55°C) yielding pinker interiors in deoxymyoglobin-dominant samples.^[86]^[87] In chemical processing like curing, nitrates are reduced to nitrites, which react with myoglobin to form nitrosylmyoglobin, a bright red pigment that, upon heating, converts to the heat-stable nitrosohemochrome, maintaining a characteristic pink-red color in processed meats even after cooking to temperatures exceeding 70°C.^[88]^[89] This stabilization prevents the typical browning from denaturation, enhancing visual stability under vacuum or light exposure, though the pigment fades in air.^[90] Culinary implications include altered sensory perception of doneness, where denatured myoglobin contributes to the opaque, browned appearance signaling "cooked" status, influencing consumer preferences for rarer preparations that retain native red oxymyoglobin for juiciness and flavor associations.^[91] In cured products, the persistent pink hue supports uniform aesthetics in items like sausages or hams, but requires precise control of nitrite levels to avoid over-stabilization mimicking undercooking.^[92] These effects underscore myoglobin's role in balancing food safety endpoints with desirable texture and color retention during grilling, roasting, or smoking.^[85]

Synthetic and Engineered Variants

Design of Myoglobin Analogues

The design of synthetic myoglobin analogues via chemical synthesis focuses on replicating the heme group's reversible dioxygen-binding capability, particularly the steric and electronic environment of the distal pocket that stabilizes the bound O₂ and prevents unwanted side reactions.^[93] Early efforts with simple iron porphyrins failed to achieve this, as exposure to O₂ led to rapid autooxidation and formation of stable μ-oxo diiron(III) dimers, mimicking the irreversible reactivity observed outside the protein matrix.^[94] This dimerization arises from nucleophilic attack by a second Fe(II) center on the bound O₂, forming a bridged peroxide intermediate that disproportionates, thereby challenging the creation of functional models without protein encapsulation.^[95] To overcome these obstacles, researchers engineered porphyrins with asymmetric steric bulk to enforce a protected binding pocket, directing end-on O₂ coordination akin to native myoglobin and hindering intermolecular dimerization.^[93] A landmark achievement was the 1975 development of "picket fence" porphyrins by James P. Collman and colleagues, utilizing meso-tetrakis(α,α,α,α-o-pivalamidophenyl)porphyrin iron(II), where four pendant pivalamido "pickets" on one porphyrin face create a cleft deep enough to sequester the O₂ ligand while allowing access via the opposite face for a proximal imidazole base.^[95] This architecture not only prevented dimerization but enabled reversible O₂ binding at ambient temperature in non-aqueous solvents, with the oxy-adduct displaying bent Fe-O-O geometry and ν(O-O) stretching frequency around 1130 cm⁻¹, closely resembling oxy-myoglobin values.^[95] Subsequent refinements, such as cobalt-substituted picket fence variants, demonstrated comparable O₂ affinities to cobalt-reconstituted myoglobin, underscoring the model's fidelity in emulating proximal histidine tuning of ligand affinity.^[96] These synthetic constructs provided foundational insights into heme-O₂ chemistry, including the role of distal steric constraints in discriminating against CO versus O₂ binding, with discrimination factors (M values) tunable over orders of magnitude through peripheral modifications.^[93] Despite successes, challenges persist in achieving aqueous solubility and stability under physiological conditions without irreversible oxidation, limiting direct biomedical translation but advancing fundamental understanding of oxygen carrier design.^[94]

Plant-Based and Recombinant Production

Recombinant production of myoglobin typically involves expression in microbial hosts such as Escherichia coli or yeast species like Saccharomyces cerevisiae. In E. coli, engineered strains facilitate heme cofactor incorporation, enabling yields of holomyoglobin (heme-bound form) through optimized expression vectors and co-expression of heme biosynthesis pathways, though specific titers for myoglobin range from milligrams per liter depending on conditions.^[97] In yeast, bovine myoglobin expression reached nearly 1% of total extractable protein, confirming functional heme binding via spectroscopic analysis.^[98] Purification often includes affinity chromatography and size-exclusion steps to isolate apo- (heme-free) or holo-forms, with protocols adapted for mutants or high-purity needs.^[99] Plant-based production offers an alternative platform leveraging transient expression systems in species like Nicotiana benthamiana for scalable, heme-integrated myoglobin synthesis. A 2020 study demonstrated human myoglobin production via Agrobacterium-mediated delivery of a tobacco mosaic virus-based vector (pJL-TRBO), targeting cytosolic or chloroplastic localization without external heme supplementation, as endogenous plant heme suffices for holoprotein assembly.^[100] Yields varied by infiltration method: agroinfiltration achieved approximately 210 mg/kg fresh leaf weight, while agrospray yielded 60–80 mg/kg, with the latter scalable for field application.^[100] Purification from plant extracts involved heat denaturation at 60°C for 10 minutes to remove heat-labile contaminants, followed by ammonium sulfate precipitation at 2.28 M and anion-exchange chromatography on HiTrap Q-Sepharose, attaining ~65% purity pre-chromatography and spectral ratios (A540/A274) up to 0.389 indicative of functional holo-myoglobin.^[100] The plant-derived myoglobin exhibited native-like ligand binding (e.g., oxygen, carbon monoxide), autoxidation rates of 0.046 ± 0.004 h⁻¹, and thermal stability with melting temperatures of 73.5°C (oxy-form) and 78.9°C (carboxy-form), validating its utility as a heme-protein source.^[100] This approach highlights plants' potential for cost-effective production of oxygen-binding proteins, bypassing microbial heme limitations.^[100]

Potential Therapeutic Uses

Engineered variants of myoglobin have been explored for their potential to serve as components in hemoglobin-based oxygen carriers (HBOCs), leveraging the protein's monomeric heme-binding structure as a model for designing stable, cell-free oxygen transport systems. Studies have demonstrated that mutations enhancing heme retention in recombinant myoglobin could inform the development of safer HBOCs by reducing dissociation and associated oxidative damage, though clinical translation remains limited by broader HBOC challenges such as nitric oxide scavenging leading to vasoconstriction and hypertension.^[101]^[102] Gene therapy approaches involving myoglobin overexpression have shown promise in mitigating ischemia-reperfusion injury by facilitating intracellular oxygen storage and ATP preservation, as evidenced in rat models where hepatic transduction with myoglobin cDNA reduced injury markers and improved energy homeostasis post-ischemia.^[103] However, skeletal muscle-specific overexpression in transgenic mice has paradoxically impaired perfusion recovery and angiogenesis following hind-limb ischemia, potentially due to altered oxygen gradients disrupting vascular remodeling signals.^[104]^[105] These conflicting outcomes highlight the context-dependent effects of myoglobin modulation, with protective roles in acute hepatic settings but inhibitory impacts on chronic ischemic adaptation in striated muscle. Targeted delivery of oxygen-bound myoglobin has been proposed to enhance radiotherapy outcomes in hypoxic tumors by increasing local oxygenation and radiosensitivity, with in vitro and xenograft studies indicating improved tumor control when myoglobin is conjugated to tumor-homing peptides.^[106] Despite these preclinical advances, no myoglobin-derived therapeutics have progressed to human trials, underscoring persistent concerns over immunogenicity, heme instability, and off-target effects in vivo.^[107]

Recent Advances and Research Directions

Studies on Expression Regulation

Expression of the myoglobin (MB) gene in skeletal muscle is primarily regulated at the transcriptional level by hypoxia-inducible factors (HIFs), which respond to oxygen deprivation by stabilizing HIF-1α and promoting MB transcription as an adaptive mechanism to enhance oxygen storage and diffusion.^[108] Studies demonstrate that hypoxia alone induces modest increases in myoglobin mRNA, but synergistic effects with muscle contraction—via elevated intracellular calcium and calcineurin activation—significantly amplify MB expression, leading to up to 4-fold elevations in protein levels under combined stimuli.^[109] This regulation involves hypoxia-responsive elements in the MB promoter, though the exact HIF-binding affinity remains debated, with some evidence suggesting indirect modulation through calcium flux reprogramming rather than direct HIF transactivation in all muscle types.^[110] In non-muscle tissues, such as epithelial cells and renal carcinoma lines, hypoxia similarly upregulates myoglobin via HIF-independent pathways in some cases, with increases up to 62-fold observed in vitro, potentially linking expression to prolyl-hydroxylase modulation and altered HIF-1α stability.^[111] Comprehensive reviews highlight that MB expression is also influenced by muscle fiber type specification factors, with oxidative slow-twitch fibers exhibiting baseline higher levels due to sustained calcineurin signaling, while fast-twitch fibers require chronic hypoxic training for induction.^[112] Interventional studies targeting MB overexpression have explored therapeutic potential in age-related muscle decline. In aged mice (24 months), NOR-1 (neuron-derived orphan receptor 1) overexpression via gene delivery elevated myoglobin levels through PERM1 (PPARGC1- and ERR-induced regulator, muscle 1) mediation, resulting in enhanced mitochondrial respiration, fatigue resistance, and endurance performance comparable to young controls.^[113] This approach counters sarcopenic reductions in oxidative capacity, where baseline myoglobin declines correlate with diminished oxygen handling, though human translation remains limited by delivery efficiency and off-target effects.^[114] Conversely, transgenic myoglobin overexpression in ischemic models has shown mixed outcomes, sometimes impairing reperfusion angiogenesis, underscoring context-specific regulatory feedback.^[115]

Insights into Heme Protein Pathophysiology

Myoglobin and hemoglobin, as major heme-containing proteins, can exacerbate oxidative stress in various disease states by facilitating the generation of reactive oxygen species (ROS) through heme iron-mediated catalysis. Under conditions of cellular stress, such as ischemia-reperfusion injury or rhabdomyolysis, the release of free heme from these proteins promotes Fenton-like reactions, leading to hydroxyl radical formation and subsequent lipid peroxidation, protein oxidation, and DNA damage.^[116] This mechanism underlies tissue injury, particularly in the kidney, where myoglobinuric damage disrupts mitochondrial function and uncouples oxidative phosphorylation, amplifying ROS production and cellular dysfunction.^[117] In hemolytic disorders or hypoxic stress, hemoglobin similarly contributes by oxidizing to methemoglobin, releasing ferryl heme species that propagate oxidative cascades, independent of oxygen-binding roles.^[116] These heme proteins' involvement in ROS dynamics extends to chronic stress responses, where dysregulated nitric oxide (NO) interactions further intensify pathophysiology. Myoglobin's peroxidase-like activity, while potentially scavenging peroxynitrite under normoxia, shifts to pro-oxidant behavior during heme destabilization, fostering nitro-oxidative stress in affected tissues.^[118] Recent analyses confirm that such mechanisms do not correlate with reduced oxidative defense in hemoglobin/myoglobin-deficient models but rather highlight heme release as a primary driver of damage in wild-type systems under acute stress.^[119] In diabetic models, hyperglycemia induces non-enzymatic glycation of myoglobin, forming advanced glycation end products (AGEs) that alter heme pocket conformation and impair oxygen storage, thereby reinforcing insulin resistance via impaired muscle oxygenation and metabolic feedback loops.^[120] Site-specific glycation, particularly with reducing sugars like glucose or melibiose, generates stable adducts such as methylglyoxal-derived hydroimidazolone, which disrupt iron coordination and enhance auto-oxidation rates, linking protein modification to elevated ROS and vascular complications.^[121] Elevated plasma myoglobin levels in type 2 diabetes correlate mechanistically with glycation-induced renal tubular injury, where modified myoglobin exacerbates glomerular hyperfiltration and fibrosis through sustained oxidative and inflammatory signaling.^[122] These processes illustrate a causal pathway from glycation to heme protein dysfunction, distinct from hemoglobin's predominant vascular effects.^[120]

Emerging Biomedical and Industrial Applications

Myoglobin's species-specific amino acid sequences enable its use as a biomarker in the food industry for authenticating meat origins and detecting adulteration, particularly through mass spectrometry targeting unique peptides derived from myoglobin isoforms across species such as beef, pork, horse, and lamb. Multiple reaction monitoring (MRM) assays have achieved detection limits as low as 0.5% contaminant levels in processed meats, facilitating rapid identification even after cooking or processing.^[123]^[124] This approach leverages myoglobin's thermal stability and solubility, providing a reliable alternative to DNA-based methods for traceability in commercial supply chains.^[125] In biomedical research, myoglobin is investigated as a targeted oxygen carrier to alleviate hypoxia in pathological tissues, with preclinical studies demonstrating its potential to deliver oxygen directly to hypoxic cancer cells, thereby enhancing the efficacy of radiation or chemotherapeutic interventions. For example, conjugation of myoglobin to tumor-targeting moieties has shown increased intracellular oxygenation in vitro, reducing tumor resistance to oxidative therapies.^[106] However, translation to clinical hemoglobin-based oxygen carriers (HBOCs), which share mechanistic similarities with myoglobin in heme-mediated oxygen binding, has been hindered by adverse effects including vasoconstriction from nitric oxide scavenging, oxidative stress, and elevated myocardial infarction risk observed in phase III trials of products like Hemopure and Hemospan.^[126]^[102] These failures highlight inherent challenges in free heme proteins, such as auto-oxidation and lipid peroxidation, necessitating advanced protein engineering for safer myoglobin variants, though none have yet progressed beyond preclinical stages as of 2025.^[127]

References

[1]
Biochemistry, Myoglobin - StatPearls - NCBI Bookshelf - NIH
Myoglobin facilitates oxygen diffusion. Myoglobin desaturates at the onset of muscle activity, which increases oxygen's diffusion gradient from the capillaries ...Introduction · Molecular Level · Function · Testing
[2]
Myoglobin's old and new clothes: from molecular structure to ...
Myoglobin, a mobile carrier of oxygen, is developed in red muscle and heart cells in response to increased demand for oxygen during exercise and transports ...
[3]
Gene: MB (ENSG00000198125) - Summary - Homo_sapiens
Chromosome 22: 35,606,764-35,637,951 reverse strand. ... This gene has 20 transcripts (splice variants), 206 orthologues, 11 paralogues and is associated with 1 ...
[4]
The human myoglobin gene: a third dispersed globin locus in the ...
Somatic cell hybrids containing translocation chromosomes carrying part of chromosome 22 were used to locate the myoglobin gene to the region 22q11 → 22q13.
[5]
John Kendrew and myoglobin: Protein structure determination ... - NIH
The essay reviews John Kendrew's pioneering work on the structure of myoglobin for which he shared the Nobel Prize for Chemistry in 1962.
[6]
John C. Kendrew – Facts - NobelPrize.org
John Kendrew became the first person to successfully determine the atomic structure of a protein. He had unlocked the structure of myoglobin.
[7]
Myoglobin and Mitochondria: A relationship bound by Oxygen and ...
Myoglobin modulates mitochondrial function by regulating oxygen and nitric oxide levels, and they are intimately linked in their functional regulation.
[8]
Myoglobin: Just an Oxygen Store or Also an Oxygen Transporter?
Besides acting as an oxygen store during times of reduced blood oxygen supply, myoglobin can also facilitate intracellular oxygen transport.
[9]
Historical perspectives of cellular oxygen sensing and responses to ...
Apr 1, 2000 · It is fundamentally different from myoglobin and hemoglobin, removing the confusion that previously existed. Warburg's views on cytochrome in ...
[10]
Researches on myohaematin and the histohaematins / by C.A. ...
Researches on myohaematin and the histohaematins / by C.A. MacMunn. MacMunn, Charles Alexander, 1852-1911. Date: 1886. Books. Online. Available online. view ...Missing: myohematin | Show results with:myohematin
[11]
Unmasking the Janus face of myoglobin in health and disease
Aug 15, 2010 · Myoglobin was discovered spectroscopically by Mörner in 1897 (Mörner, 1897). In order to distinguish this muscle pigment – noted as muscle ...
[12]
[PDF] Hugo Theorell - Nobel Lecture
of hemoglobin, the myochrome or, as it was afterwards called, the myoglobin discovered spectroscopically by K. A. H. Mörner in 1897, and had crys- tallized ...
[13]
Crystallization of Whale Myoglobin - Nature
ALTHOUGH the spectroscopic differences between blood and muscle hæmoglobin were first observed by Mörner1 in 1897, it was not until 1932 that Theorell2 ...Missing: discovery | Show results with:discovery
[14]
The crystal structure of myoglobin III. Sperm-whale ... - Journals
Myoglobin of Physeter catodon (sperm whale) forms monoclinic crystals with space group P2 1 (type A) in ammonium sulphate, and orthorhombic crystals.
[15]
The crystal structure of myoglobin IV. A Fourier projection of sperm ...
Two methods were used to attach heavy atoms to specific sites on the myoglobin molecule in type A crystals: (i) the use of specific reagents for the haem ...
[16]
(International Tables for Crystallography) Historical background
The 2 Å resolution structure of myoglobin (Kendrew, 1959) confirmed the right-handed α-helix predicted by Pauling. Subsequently other techniques were added for ...
[17]
building the ground for the first two protein structures: myoglobin and ...
Sep 11, 2009 · They were the first to use x-ray crystallography to decipher the molecular structures of proteins: haemoglobin and myoglobin.
[18]
The first of its kind - Nature
Jul 17, 2014 · In 1960, John Kendrew and his colleagues reported the structure of sperm whale myoglobin to a resolution of 2 Å, which required the assessment ...
[19]
MB - Myoglobin - Homo sapiens (Human) | UniProtKB | UniProt
Monomeric heme protein which primary function is to store oxygen and facilitate its diffusion within muscle tissues.
[20]
Quantitative theory of hydrophobic effect as a driving force of protein ...
Various studies suggest that the hydrophobic effect plays a major role in driving the folding of proteins. In the past, however, it has been challenging to ...
[21]
[PDF] Accurate protein stability predictions from homology models - bioRxiv
Jul 13, 2022 · For example, in the case of sperm whale myoglobin, bin2 was populated using an elephant myoglobin (PDB ID: 1EMY) with a sequence identity of 81% ...<|separator|>
[22]
Protein tertiary structure and the myoglobin phase diagram - Nature
Jul 25, 2019 · We describe how myoglobin unfolds from the native folded state to a random coil when temperature and acidity increase.Missing: surface | Show results with:surface
[23]
Autonomous Sequences in Myoglobin Emerging from X-ray ...
Jan 11, 2019 · Hydrophobic core formation is indispensable to stabilize the different folding structures via an efficient hydrophobic interaction. Autonomous ...
[24]
Structural characterization of partially folded intermediates of ...
The structure of myoglobin consists of eight α-helices (designated helices A ... core and leads to stabilization of helical structure in the D and E helices.
[25]
Folding structure units in myoglobin. - ResearchGate
Here, we could elucidate for the first time two types of hydrophobic core networks in apomyoglobin using continuous folding structure units. In myoglobin, two ...
[26]
Tracing whale myoglobin evolution by resurrecting ancient proteins
Nov 15, 2018 · Here, we resurrected ancestral whale Mbs, which are from the common ancestor between toothed and baleen whales (Basilosaurus), and from a further common ...
[27]
High Resolution Crystal Structures of the Deoxy, Oxy, and Aquomet ...
The iron in the native myoglobin moves from 5-coordinate high spin (S = 2) to 6-coordinate low spin (S = 0) upon oxygenation of the ferrous protein. The cobalt ...
[28]
Distal Histidine Stabilizes Bound O2 and Acts as a Gate for Ligand ...
Ligand entry into myoglobin occurs through the distal histidine gate; hydrogen bond donation by the neutral NϵH tautomer of His(E7) regulates oxygen affinity, ...
[29]
The role of the distal histidine in myoglobin and haemoglobin
A hydrogen bond between the N epsilon proton of the distal histidine and the second oxygen atom may stabilize O2 bound to the haem iron. The proximity of the ...
[30]
Dual nature of the distal histidine residue in the autoxidation ...
Dec 25, 2001 · At the same time, the distal histidine also makes the proteins most resistant to autoxidation by way of protecting the FeO2 center from easy ...
[31]
Structure and function evolution in the superfamily of globins
The superfamily of globins has emerged some 4000 Myr from a common ancestor, which was among the basic protein components required for life.
[32]
Evolution of Myoglobin and Hemoglobin
Jan 19, 2015 · Hemoglobin evolved from myoglobin, with a gene duplication 500 million years ago. Lampreys have the most ancestral hemoglobin, and later, alpha ...
[33]
Evolutionary History of the Globin Gene Family in Annelids
Jun 29, 2020 · We probed 250 annelid transcriptomes in search of globin diversity in order to elucidate the evolutionary history of this gene family within this phylum.
[34]
[PDF] Case Study: Myoglobin
The structure of myoglobin is highly conserved across species. The overlapped structures of several myo- globins are shown in Fig. 4, colored by their sequence ...<|separator|>
[35]
Conservation of the myoglobin gene among Antarctic notothenioid ...
Myoglobin cDNA sequences were highly conserved among the species the express the protein, particularly in the coding region. Sequence variation among the ...Missing: across | Show results with:across
[36]
Myoglobin primary structure reveals multiple convergent transitions ...
Complete myoglobin coding sequences (465 base pairs including initiation and stop codons) were obtained for 55 eulipotyphlan species (38 moles, 14 shrews, 2 ...
[37]
The role of myoglobin in the evolution of mammalian diving capacity
Nov 10, 2020 · The present review focuses on the molecular properties of the respiratory protein myoglobin that has repeatedly evolved an elevated net positive surface charge.
[38]
Common and unique strategies of myoglobin evolution for deep-sea ...
Aug 20, 2021 · We previously resurrected ancestral whale Mbs and demonstrated the evolutional strategies for higher solubility under macromolecular crowding conditions.
[39]
7.3.2: Oxygen Transport by the Proteins Myoglobin and Hemoglobin
Dec 20, 2021 · The shape of the O2-binding curve of myoglobin can be described mathematically by the following equilibrium: (7.3.2.1) M ⁢ b ⁢ O 2 ⇌ M ⁢ b + O 2.
[40]
Kinetic Mechanisms for O2 Binding to Myoglobins and Hemoglobins
Dioxygen binding to myoglobin can be described macroscopically as a one step chemical reaction with the rate and equilibrium constants defined in Equation 1. Mb ...
[41]
Myoglobin oxygen affinity in aquatic and terrestrial birds and mammals
Among diving birds, the P50 ranged from 2.40 to 3.36 mmHg and also showed a trend of higher affinities in species with longer dive durations. In pinnipeds and ...
[42]
Common and unique strategies of myoglobin evolution for deep-sea ...
Aug 20, 2021 · Myoglobin (Mb) is highly concentrated in the myocytes of diving mammals such as whales and seals, in comparison with land animals, ...
[43]
Tracing whale myoglobin evolution by resurrecting ancient proteins
Nov 15, 2018 · Myoglobin (Mb) is highly concentrated in the myocytes of diving animals, in comparison with those of land animals, and is thought to play a ...
[44]
from molecular structure to function in living cells - PubMed - NIH
Aug 15, 2010 · This article reviews the current evidence underlying the evaluation of the biophysical parameters of myoglobin-facilitated oxygen diffusion in ...
[45]
Visualization of Myoglobin-Facilitated Mitochondrial O2 Delivery in a ...
According to Fick's law of diffusion, oxygen flux determines the magnitude of the extracellular (from the surface of the medium to the plasma membrane) and ...
[46]
Myoglobin Function Evaluated in Working Heart Tissue - PubMed
Previous modeling efforts suggest that myoglobin-facilitated diffusion ... Myoglobin-facilitated oxygen diffusion may be augmented by the same mechanism.
[47]
Facilitated Diffusion of Myoglobin and Creatine Kinase and Reaction ...
The model describes the steady state, free and myoglobin-facilitated diffusion of oxygen into a respiring cylindrical muscle fiber cross section. The oxygen ...
[48]
Deoxymyoglobin Is a Nitrite Reductase That Generates Nitric Oxide ...
We characterize the nitrite reductase activity of deoxymyoglobin, which reduces nitrite approximately 36 times faster than deoxyhemoglobin because of its lower ...
[49]
Nitrite reductase activity of myoglobin regulates respiration and ...
The nitrite anion is reduced to nitric oxide (NO•) as oxygen tension decreases. Whereas this pathway modulates hypoxic NO• signaling and mitochondrial ...
[50]
Nitrite Regulates Hypoxic Vasodilation via Myoglobin-Dependent ...
Jul 17, 2012 · We have shown that deoxygenated myoglobin in the heart can reduce nitrite to nitric oxide (NO·) and thereby contribute to cardiomyocyte NO· signaling during ...
[51]
Nitrite reductase activity of myoglobin regulates respiration ... - PNAS
Jul 22, 2008 · We here test the central role of myoglobin as a functional nitrite reductase that regulates hypoxic NO • generation, controls cellular respiration,
[52]
The functional nitrite reductase activity of the heme-globins | Blood
Oct 1, 2008 · As oxygen tensions decrease, nitrite reactions with deoxygenated hemoglobin, myoglobin, neuroglobin, cytoglobin, and other heme proteins may ...
[53]
Modulation of hemoglobin dynamics by an allosteric effector - PMC
19 Allosteric effectors such as 2,3 BPG and IHP bind to both the liganded and unliganded forms of Hb, albeit at different sites and resulting in different ...
[54]
[PDF] Allostery and cooperativity illustrated by hemoglobin (Hb) and ...
2,3 bisphosphoglycerate (BPG). • Allosteric effector: binds at a site different from. O. 2 and modulates Hb function. • Effect is to change equilibrium for O. 2.
[55]
Evolution of Hemoglobin and Its Genes - PMC - NIH
This article presents the multiple genes and gene families encoding human globins, summarizes major events in the evolution of the hemoglobin gene clusters,
[56]
Origin of complexity in hemoglobin evolution - PMC - NIH
We show that modern Hb evolved from an ancient monomer and characterize the historical “missing-link” through which the modern tetramer evolved.
[57]
Structural requirement of highly-conserved residues in globins
Sep 29, 1997 · The conserved residues were examined in terms of the structural stability, by employing the pseudo-energy functions of the structure/sequence compatibility ...
[58]
Evolution of Hemoglobin and Its Genes
Hemoglobin gene evolution involves dynamic b-like globin clusters, gene duplications, losses, and translocations. The a-like globin genes are relatively stable.Missing: timeline | Show results with:timeline
[59]
Rhabdomyolysis - StatPearls - NCBI Bookshelf - NIH
Rhabdomyolysis may be associated with dark reddish-colored urine due to myoglobinuria. ... Rhabdomyolysis is a major cause of AKI.[4] If identified early, the ...
[60]
Rhabdomyolysis: Symptoms, Causes & Treatments - Cleveland Clinic
This dangerous muscle condition can result from overexertion, trauma, medications or an underlying health condition. Common signs and symptoms of rhabdomyolysis ...
[61]
Statin-induced rhabdomyolysis: a complication of a commonly ... - NIH
Mar 14, 2018 · Rhabdomyolysis is a well-documented side effect of statin therapy. This risk is increased with concurrent use of medications that inhibit cytochrome p450-3A4 ( ...
[62]
A Narrative Review of Statin-Induced Rhabdomyolysis | DHPS
Nov 8, 2021 · Lastly, patients who are prescribed statins but engage in strenuous exercise also have an increased risk of rhabdomyolysis. One study showed an ...
[63]
Acute kidney injury due to rhabdomyolysis and renal replacement ...
May 28, 2014 · Myoglobin levels >15,000 μg/l were most significantly related to the development of AKI and the need for hemodialysis. Based on these results, ...
[64]
Rhabdomyolysis-Associated Acute Kidney Injury
Sep 1, 2018 · The main mechanism of kidney damage in patients with rhabdomyolysis is the massive release of myoglobin into the circulation, with myoglobinuria ...
[65]
Molecular Mechanisms of Rhabdomyolysis-Induced Kidney Injury
Rhabdomyolysis-induced acute kidney injury is caused by myoglobin. (a) Muscle takes damage and releases myoglobin and other metabolites into circulation. (b) ...
[66]
Molecular Mechanisms and Novel Therapeutic Approaches to ...
Oct 20, 2015 · Rhabdomyolysis is the breakdown of damaged skeletal muscle and subsequent release of its contents (i.e., myoglobin, sarcoplasmic proteins, and ...<|separator|>
[67]
Serum Myoglobin - StatPearls - NCBI Bookshelf - NIH
Although myoglobin is the first enzyme to be elevated in rhabdomyolysis ... rapid latex agglutination test for semi-quantitative estimation of serum myoglobin.Missing: ELISA | Show results with:ELISA
[68]
[PDF] STAT Myoglobin - accessdata.fda.gov
STAT MYO is a 2-step quantitative chemiluminescent microparticle immunoassay that determines the presence of myoglobin in human serum and plasma.
[69]
A New Immunoassay for the Measurement of Myoglobin in Serum
Our aim was to evaluate a new assay that provides a rapid, quantitative determination of Mb (Baxter Stratus Myoglobin) based on the radial partition technique.
[70]
Diagnostic Evaluation of Rhabdomyolysis - PMC - PubMed Central
Establishing a diagnosis of rhabdomyolysis is based primarily on the appearance of myoglobin in the urine (myoglobinuria) or by a marked elevation in serum CK ...
[71]
Rhabdomyolysis Workup - Medscape Reference
Feb 28, 2024 · Total CK elevation is a sensitive but nonspecific marker for rhabdomyolysis. CK levels 5 times the reference range suggest rhabdomyolysis, ...Missing: biomarker ELISA<|separator|>
[72]
Admission serum myoglobin and the development of acute kidney ...
Creatine kinase (CK) and myoglobin are both established biomarkers to diagnose and monitor rhabdomyolysis severity [6]. Many studies have reported an ...Missing: ELISA | Show results with:ELISA
[73]
Major heme proteins hemoglobin and myoglobin with respect to ...
In this review, we have discussed how heme-irons of hemoglobin and myoglobin can promote oxidative stress under different pathophysiological conditions.
[74]
Oxidation–reduction imaging of myoglobin reveals two-phase ... - NIH
Under ischemia–reperfusion experimental settings, we report that the infarcted myocardium spectral signature is similar to that of oxidized myoglobin signal ...
[75]
Myoglobin-derived iron causes wound enlargement and impaired ...
Jun 2, 2023 · Myoglobin iron contributes to the formation and poor healing of muscle pressure injuries, that is, bedsores, and iron-chelation therapy can ...
[76]
Myoglobin chemistry and meat color - PubMed
Myoglobin is the sarcoplasmic heme protein primarily responsible for the meat color, and the chemistry of myoglobin is species specific.Missing: influence quality
[77]
The color of meat depends on myoglobin: Part 1 - Agriculture
Mar 1, 2024 · The more myoglobin content meat contains the darker red it will appear in color. Myoglobin content is higher in beef and lower in poultry with ...
[78]
[PDF] AMSA Meat Color Measurement Guidelines
Myoglobin oxygenation or blooming (reaction 1 in Figure 2.1) depends on time, ... MAP packaging may reduce the residual oxygen levels more than vacuum packaging ...
[79]
Effect of Modified Atmosphere Packaging and Vacuum ... - NIH
Myoglobin is the principle protein responsible for meat color and ... and vacuum packaging result in less lipid oxidation than aerobic packaging. Lund et ...
[80]
[PDF] Comparison of Modified Atmosphere Versus Vacuum Packaging to ...
The oxygenation of myoglobin can be reversed as long as the meat is fresh. Thus, if the oxygenated ("bloomed") meat is placed in a vacuum bag or covered with a ...
[81]
[PDF] effect of specific packaging conditions on myoglobin and meat color
The shelf-life of pork chops was extended to more than 36 days in CO-MAP compared with only 28 days in traditional, high oxygen MAP, 23 days in vacuum packaging ...<|separator|>
[82]
Equations for Spectrophotometric Determination of Myoglobin ...
Aug 7, 2025 · Myoglobin is stable at greater pH; hence, a longer storage period was used at pH 7.4 to achieve similar metmyoglobin (MetMb) levels as at pH 5.6 ...
[83]
Effects of pH and temperature on metmyoglobin solubility in a model ...
Low pH (especially <5.6) causes metmyoglobin denaturation at various temperatures. Thermal stability increases with pH. Denaturation occurs at intermediate pH/ ...
[84]
The significant influences of pH, temperature and fatty acids on meat ...
Oct 27, 2020 · The PSE meat is caused by its abnormally low pH (~ 5.3) that results in denaturation of myofibril proteins (e.g., myoglobin etc.) (Smith and ...
[85]
Change in Myoglobin Denaturation and Physiochemical Properties ...
Mar 14, 2024 · While the current study aimed to look at the impact of DOD and muscle on pH, other studies have evaluated the cooked color stability differences ...
[86]
Color and Heat Denaturation of Myoglobin Forms in Ground Beef
Jun 28, 2008 · Only patties with DMb appeared red and undercooked at 55 °C, and their color became progressively more brown at 65 and 75 °C. Patties with OMb ...<|separator|>
[87]
[PDF] Effects of pH, myoglobin form, and endpoint temperature on cooked ...
Myoglobin Denaturation for Oxymyoglobin and Deoxymyoglobin Ground Beef. Patties at Each Cooking Temperature Averaged over pH. Myoglobin. 150°F. 160°F. 170°F.
[88]
Nitrites in Cured Meats, Health Risk Issues, Alternatives to Nitrites
The bright red nitrosyl-myoglobin complex provides the foundation for the distinct color of cured meat [38]. This complex is extremely unstable, and it turns ...
[89]
Understanding the Cured Meat reaction | The National Provisioner
Aug 25, 2008 · Nitrosomyoglobin is the dark red color of cured meat which has not been heated. When nitrosomyglobin is exposed to heat, nitrosohemochrome ...Missing: stabilization | Show results with:stabilization
[90]
American Meat Science Association Guidelines for Meat Color ...
Feb 2, 2023 · The guidelines provide an overview of myoglobin chemistry, perceptions of meat color, details of instrumentation used inmeat color evaluation, and step-by-step ...
[91]
Heat and Its Effects on Muscle Fibers in Meat - ThermoWorks Blog
This change occurs at 140°F (60°C). When protein molecules denature, their coiled structure unfolds.
[92]
Nitrite and nitrate in meat processing: Functions and alternatives
Nitrite or nitrate can produce a pinkish-red color via interaction with the myoglobin in muscle. In addressing the food safety concerns, most researchers have, ...
[93]
Functional Analogues of Cytochrome c Oxidase, Myoglobin, and ...
Appropriately positioned hydrogen bonds can dramatically increase the O2 affinity: for example, the 104-fold higher O2 affinity of a unique hemoglobin from the ...
[94]
Lessons from Nature: A Bio-Inspired Approach to Molecular Design
The second major challenge in designing a synthetic system that is capable of reversibly binding O2 is preventing irreversible oxidation to oxo-bridged dimers.
[95]
Picket fence porphyrins. Synthetic models for oxygen binding ...
Iron dioxygen adduct formed during electrochemical oxygen reduction by iron porphyrins shows catalytic heme dioxygenase reactivity.
[96]
[PDF] Oxygen Binding to Cobalt Porphyrins
Abstract: The thermodynamic constants of oxygen binding to cobalt “picket fence” porphyrin ... bind oxygen with the same affinity as cobalt substituted myoglobin ...
[97]
Improved Method for the Incorporation of Heme Cofactors into ...
Apr 16, 2018 · Here we describe the use of the apathogenic E. coli strain Nissle 1917 (EcN) as a suitable host for the recombinant production of heme proteins.
[98]
Expression of bovine myoglobin cDNA as a functionally ... - PubMed
The amount of myoglobin reached nearly 1% of the total extractable protein in the yeast. N-terminal sequence analysis of the produced myoglobin revealed a ...
[99]
Fast purification of the Apo form and of a non-binding heme mutant ...
Fast purification of the Apo form and of a non-binding heme mutant of recombinant sperm whale myoglobin. Protein Expr Purif. 2003 Mar;28(1):202-8.
[100]
Plant based production of myoglobin - a novel source of the muscle ...
Jan 22, 2020 · Myoglobin is a heme-protein in the muscle of vertebrates with important functions in the oxygenation of tissues and as a regulator in nitric ...
[101]
Significantly Enhanced Heme Retention Ability of Myoglobin ...
This investigation holds promise for engineering heme stability in recombinant hemoglobin-based oxygen carriers (rHBOCs) for potential use as an artificial ...Missing: therapeutic | Show results with:therapeutic
[102]
Hemoglobin‐based oxygen carriers: Biochemical, biophysical ...
Jan 2, 2025 · Many HBOCs are derived from human outdated blood prior to chemical modifications with minimal purification steps that remove other red cell ...
[103]
Myoglobin gene expression attenuates hepatic ischemia reperfusion ...
These results indicate that myoglobin gene transfer to the liver enhanced ATP levels both in vitro and in vivo and might be a novel strategy to reduce ...
[104]
Myocyte Specific Overexpression of Myoglobin Impairs ...
In summary, data from this study show that increased myoglobin expression in skeletal myocytes attenuates perfusion recovery after hind-limb ischemia, in part, ...
[105]
Myoglobin Overexpression Inhibits Reperfusion in the Ischemic ...
Here, we tested the hypothesis that myoglobin overexpressing transgenic mice (MbTg+) exhibit impaired angiogenesis in the setting of normal arteriogenesis in ...
[106]
Article Targeted Myoglobin Delivery as a Strategy for Enhancing the ...
Jun 26, 2020 · These findings suggest that the targeted delivery of O 2 -bound myoglobin could be an effective approach to enhance the efficacy of radiotherapy.
[107]
Taming hemoglobin chemistry—a new hemoglobin-based oxygen ...
Oct 1, 2024 · Artificial hemoglobin (Hb)-based oxygen carriers (HBOCs) ... Myoglobin as a model system for designing heme protein based blood substitutes.
[108]
Hypoxia reprograms calcium signaling and regulates myoglobin ...
Numerous studies have implicated hypoxia in the regulation of myoglobin expression as an adaptive response to hypoxic stress. However, the details of this ...
[109]
Both hypoxia and work are required to enhance expression of ...
Rather, hypoxia acts by differentially regulating the intracellular pools of calcium, which signal the regulation of myoglobin gene expression.
[110]
Extensive transcriptional complexity during hypoxia-regulated ...
The degree of hypoxia-responsivity of the MB gene in the classic context of muscle cells has been a debated issue (38–42). Recent work showed that while the Mb ...
[111]
Myoglobin expression in renal cell carcinoma is regulated by hypoxia
In renal cell carcinoma cell lines hypoxia induced a significant increase of myoglobin expression up to 62 fold, whereas hypoxia-inducible-factor-1α only ...<|separator|>
[112]
(PDF) Regulation of myoglobin expression - ResearchGate
Aug 6, 2025 · factors modulating muscle fiber type specification. Role of hypoxia and calcium fluxes in regulating myoglobin. expression. As mentioned ...
[113]
NOR‐1 Overexpression Elevates Myoglobin Expression via PERM1 ...
Apr 16, 2025 · We found that the overexpression of NOR‐1 in aged muscle results in enhanced muscle endurance, mitochondrial respiration, and elevated ...
[114]
NOR‐1 Overexpression Elevates Myoglobin Expression via PERM1 ...
Apr 16, 2025 · NOR-1 overexpression elevates myoglobin expression via PERM1 and enhances mitochondrial function and endurance in skeletal muscles of aged mice.
[115]
Myoglobin Overexpression Inhibits Reperfusion in the Ischemic ...
Here, we tested the hypothesis that myoglobin overexpressing transgenic mice (MbTg+) exhibit impaired angiogenesis in the setting of normal arteriogenesis in ...
[116]
Major heme proteins hemoglobin and myoglobin with respect to ...
On the other hand, myoglobin, with its higher affinity for oxygen, is involved in oxygen storage in cardiac and skeletal muscle tissues.Major Heme Proteins... · 2 Free Heme, A Major Source... · 4 Heme Proteins And...<|separator|>
[117]
Myoglobin causes oxidative stress, increase of NO production and ...
We speculate that rhabdomyolysis-induced kidney damage involves direct interaction of myoglobin with mitochondria possibly resulting in iron ions release.
[118]
Myoglobin Protects Breast Cancer Cells Due to Its ROS and NO ...
Oct 3, 2021 · It may function as a temporary storage and transport protein for O2 but could also have scavenging capacity for reactive oxygen and nitrogen ...
[119]
The loss of hemoglobin and myoglobin does not minimize oxidative ...
Our data indicate that the loss of Hb and Mb does not correspond with a clear pattern of either reduced oxidative defense or oxidative damage.
[120]
Identifying myoglobin as a mediator of diabetic kidney disease
Dec 10, 2022 · We developed DKD ML models incorporating serum Mb and metabolic syndrome (MetS) components (insulin resistance and β-cell function, glucose, ...
[121]
Analysis of the Site-Specific Myoglobin Modifications in the ...
Oct 27, 2022 · Our study showed the structural in vitro obtained analogous adduct (MAGE) forming during glycation on a variety of proteins exposed to melibiose ...
[122]
Elevated plasma myoglobin level is closely associated with type 2 ...
Nov 30, 2023 · This study shows that elevated plasma myoglobin level is closely associated with the development of kidney injury in patients with T2DM.
[123]
Meat Authentication via Multiple Reaction Monitoring Mass ...
Oct 20, 2015 · The approach is introduced by use of myoglobin from four meats: beef, pork, horse and lamb. Focusing in the present work on species ...Missing: isoforms | Show results with:isoforms
[124]
Peptidomics approaches for meat authentication employing rapid in ...
Myoglobin and Carbonic anhydrase-3 identified as potential heat-stable markers. •. Peptidomics approach detects as low as 0.5 % w/w contaminating pork in ...
[125]
Myoglobin as a molecular biomarker for meat authentication and ...
Myoglobin as a molecular biomarker for meat authentication and traceability ... meat fraud authentication. Mb is highly soluble in water ...Missing: isoforms | Show results with:isoforms
[126]
Hemoglobin-Based Oxygen Carriers: Where Are We Now in 2023?
Feb 17, 2023 · Past and Present HBOC Products Approved for Clinical Trials. Here we will discuss some of the most representative products which either ...
[127]
Hemoglobin-Based Oxygen Carriers: Selected Advances ... - MDPI
Recent HBOC research has shifted toward the development of bioengineered oxygen carriers designed to mimic the structure and function of human hemoglobin. These ...